Inactivation of indispensable bacterial proteins by early proteins of bacteriophages: implication in antibacterial drug discovery

• Published in: Current protein & peptide science Vol. 9; no. 3; p. 284
• Main Authors: Sau, S, Chattoraj, P, Ganguly, T, Chanda, P K, Mandal, N C
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01-06-2008
• Subjects: Animals; Anti-Bacterial Agents - chemistry; Bacterial Proteins - antagonists & inhibitors; Bacteriophages - metabolism; Cell Wall - metabolism; Drug Design; Humans; Transcription, Genetic; Viral Proteins - metabolism
• ISSN: 1389-2037
• DOI: 10.2174/138920308784533970

Bacteriophages utilize host bacterial cellular machineries for their own reproduction and completion of life cycles. The early proteins that phage synthesize immediately after the entry of their genomes into bacterial cells participate in inhibiting host macromolecular biosynthesis, initiating phage-specific replication and synthesizing late proteins. Inhibition of synthesis of host macromolecules that eventually leads to cell death is generally performed by the physical and/or chemical modification of indispensable host proteins by early proteins. Interestingly, most modified bacterial proteins were shown to take part actively in phage-specific transcription and replication. Research on phages in last nine decades has demonstrated such lethal early proteins that interact with or chemically modify indispensable host proteins. Among the host proteins inhibited by lethal phage proteins, several are not inhibited by any chemical inhibitor available today. Under the context of widespread dissemination of antibiotic-resistant strains of pathogenic bacteria in recent years, the information of lethal phage proteins and cognate host proteins could be extremely invaluable as they may lead to the identification of novel antibacterial compounds. In this review, we summarize the current knowledge about some early phage proteins, their cognate host proteins and their mechanism of action and also describe how the above interacting proteins had been exploited in antibacterial drug discovery.